AUSTIN, Texas, April 9, 2024 /PRNewswire/ — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first in the nation to use a novel pulsed field ablation (PFA) system to treat patients with paroxysmal and persistent atrial…
Tag: TCAI
TCAI leader participates in clinical trial for catheter that may prevent rare, life-threatening complication during cardiac ablation
AUSTIN, Texas, Feb. 12, 2021 /PRNewswire/ — A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is among the first in the world to participate in a clinical trial to evaluate the safety and efficacy of a new cardiac-specific […]
TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders
AUSTIN, Texas, Feb. 5, 2021 /PRNewswire/ — Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures […]
First hospitals in U.S. implant next-generation cardiac device to reduce risk of stroke
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Los Robles Health System perform near simultaneous implantation of WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) AUSTIN, Texas, Aug. 7, 2020 /PRNewswire/ — On Aug. 5, 2020, physicians at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center opening new Electrophysiology Center
AUSTIN, Texas, June 4, 2019 /PRNewswire/ — The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is opening a new, state-of-the-art Electrophysiology Center dedicated to treating patients with cardiac arrhythmias. The new Electrophysiology Center is set to open at the end of […]
Texas Cardiac Arrhythmia Institute of St. David’s Medical Center is the first in the United States to treat patient under study for evaluation of the ablation catheter-balloon for the treatment of atrial fibrillation
AUSTIN, Texas , February 13, 2019 / PRNewswire / – The Texas Cardiac Arrhythmia Institute (TCAI) of St. David’s Medical Center recently conducted the first procedure in the United States using the new multi-electrode radiofrequency (RF) ablation balloon catheter, HELIOSTAR as […]
BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies
Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that […]